SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 5,085.56 |
| Enterprise Value ($M) | 4,169.35 |
| Book Value ($M) | 1,511.58 |
| Book Value / Share | 9.17 |
| Price / Book | 3.36 |
| NCAV ($M) | 940.85 |
| NCAV / Share | 5.71 |
| Price / NCAV | 5.41 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | 0.22 |
| Return on Assets (ROA) | 0.17 |
| Return on Equity (ROE) | 0.28 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 2.99 |
| Current Ratio | 3.41 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 1,511.24 |
| Assets | 2,081.98 |
| Liabilities | 570.39 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 1,557.63 |
| Operating Income | 420.64 |
| Net Income | 367.07 |
| Earnings Per Share Basic And Diluted | n/a |
| Earnings Per Share Diluted | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 439.12 |
| Cash from Investing | -111.31 |
| Cash from Financing | -494.14 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G | State Street Corp | 4.90 | -14.22 | |
| 13G/A | BlackRock, Inc. | 15.80 | -14.60 | |
| 13G/A | Wellington Management Group Llp | 4.30 | -44.60 | |
| 13G | Price T Rowe Associates Inc /md/ | 7.90 | 727.77 | |
| 13G/A | Vanguard Group Inc | 11.52 | 0.00 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 191,723 | 780,708 | 24.56 | |
| 246,265 | 940,427 | 26.19 | |
| 217,961 | 1,040,882 | 20.94 | |
| 228,812 | 1,179,145 | 19.40 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| AGIO – Agios Pharmaceuticals, Inc. | AKRO – Akero Therapeutics, Inc. |
| ALEC – Alector, Inc. | ALLK – Allakos Inc. |
| ALLO – Allogene Therapeutics, Inc. |
Financial data and stock pages provided by
Fintel.io